Currently, Vaxcyte Inc [PCVX] is trading at $52.73, down -2.04%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PCVX shares have gain 9.76% over the last week, with a monthly amount glided 9.69%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vaxcyte Inc [NASDAQ: PCVX] stock has seen the most recent analyst activity on January 07, 2026, when Needham reiterated its Buy rating and also boosted its price target to $110 from $90. Previously, Goldman started tracking the stock with Neutral rating on September 12, 2025, and set its price target to $38. On April 22, 2025, Cantor Fitzgerald initiated with a Overweight rating. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $135 on December 20, 2024. Mizuho initiated its recommendation with a Buy and recommended $69 as its price target on December 07, 2023. In a note dated January 03, 2023, Needham reiterated an Buy rating on this stock and boosted its target price from $52 to $58.
This stock has fluctuated between a low of $27.66 and a high of $93.77 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $77 within the next 12 months. Vaxcyte Inc [NASDAQ: PCVX] shares were valued at $52.73 at the most recent close of the market. An investor can expect a potential return of 46.03% based on the average PCVX price forecast.
Analyzing the PCVX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.21 and Total Capital is -0.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vaxcyte Inc [NASDAQ:PCVX] is 8.83. Also, the Quick Ratio is 8.83, while the Cash Ratio stands at 1.41.
Transactions by insiders
Recent insider trading involved Dhaliwal Harpreet S., Chief Technical Ops Officer, that happened on Dec 31 ’25 when 9743.0 shares were sold. Officer, HARPREET DHALIWAL completed a deal on Dec 31 ’25 to buy 9743.0 shares. Meanwhile, SVP, FINANCE Cowan Elvia sold 11623.0 shares on Dec 23 ’25.
